Page values for "WSI24-68-Case-4"

From MGH Learn Pathology

"_pageData" values

_creationDateApril 3, 2024
_modificationDateSeptember 3, 2024
_creatorSi787
_fullText{{ServiceRequestCase |identifier=WSI24-68-Case-4 |intent=order |code=cme |category=409073007 |subject=MGH |requester=Jg67 |performer=Jg67 |orderDetail=case |locationCode=MGH |access=Public |status=active |origin=CPOE |priority=Routine |basedOn=WSI24-68 |requisition=Lower GI tract slide session |reas ...
_numRevisions2
_isRedirectNo

"_fileData" values

"ServiceRequest" values

identifierWSI24-68-Case-4
basedOnWSI24-68
requisitionLower GI tract slide session
intentorder
category409073007
priorityRoutine
codecme
orderDetailcase
subjectMGH
occurrenceDateTimeMay 6, 2024 3:30:00 PM
authoredOnApril 3, 2024 4:26:26 PM
requesterJg67
performerJg67
locationCodeMGH
reasonCode41 y.o. female with breast cancer on pembrolizumab.
supportingInfoImmune checkpoint inhibitor therapy effect (increased intraepithelial lymphocytes)
specimennull
bodySitenull
sequence4
accessPublic

"Media" values

identifier5eceff16-5593-4b38-8140-5035ef1f9399
basedOnWSI24-68-Case-4
partOfWSI24-68
statusactive
typenull
modalitymrxs
viewshow
operatorJg67
reasonCodeH&E
bodySitenull
frames1
content5eceff16-5593-4b38-8140-5035ef1f9399.mrxs
notenull
subjectnull

"status" values

statusactive
identifierWSI24-68-Case-4
requesterJg67
authoredOnApril 3, 2024 4:26:26 PM